(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver-based life sciences company innovating in the field of photodisinfection therapies - Concludes the first development phase of a new food-safe photodisinfection technology from Canada's meat packing industry. Ondine's photodisinfection is a patented technology using a photosensitizer - a non-antibiotic, light-activated solution - to destroy pathogens. Read More
Ondine Biomedical Inc - Canadian life sciences company focused in the field of photodisinfection therapies - Steriwave, Ondine's nasal photodisinfection therapy, has been found to improve short- and long-term immune responses while also "significantly" reducing SARS-CoV-2 infectivity. This effect was detectable not only in antibody-mediated immunity, but also in T-cell mediated immunity. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc on Monday said it received regulatory approval from the Mexican Federal Commission for Protection against Health Risks, known as Cofepris, for the use of its Steriwave photodisinfection technology. Read More
(Alliance News) - Ondine Biomedical Inc on Monday said it has received funding towards the development of a food-safe photodisinfection method, to be used in Canada's meat packing industry. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on this week and not separately reported by Alliance News: Read More
(Alliance News) - Ondine Biomedical Inc said on Friday that the phase two trial of a nasal photodisinfection treatment showed positive results in reducing surgical site infection for pre-surgical patients. Read More
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Appoints medical device distributor, Distrauma Medical SL, to distribute its Steriwave nasal photodisinfection in Spain. Distrauma, a national medical device supplier focusing on surgical equipment for hospitals, is headquartered in Barcelona, Spain. "The primary application for Steriwave nasal photodisinfection is nasal decolonization for the prevention of healthcare-associated infections, including surgical site infections," Ondine says. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Says the Ottawa Hospital in the Canadian capital has chosen Ondine's photodisinfection technology for a three-month pilot evaluation of a non-antibiotic protocol to prevent infections in spine surgery patients. Says nasal decolonisation is recommended by World Health Organization to reduce surgical site infections in spine surgeries. Ondine says the technology has already been deployed in a few Canadian hospitals, where it has reduced post-operative infection rates for spine surgeries by 78%. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Publication by Toronto-based research firm Nature show a 90% decrease in viral infectivity of SARS-CoV-2 in patient samples following the use of Ondine's nasal antimicrobial photodynamic disinfection, with 70% of samples completely inactivated from a single 5-minute treatment. Read More
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Recruits the final patient to its nasal photodisinfection exploratory phase two trial. The trial is evaluating how effectively Ondine's photodisinfection technology eradicates pathogens, specifically staphylococcus aureus, in the rose. The firm has recruited over 300 patients. Read More
(Alliance News) - Ondine Biomedical Inc on Tuesday said its nasal photodisinfection technology suppressed SARS-CoV-2, the virus that causes Covid-19, in patients who were vaccinated against Covid-19 and had early symptoms of the disease. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More